Hello, we are GA-map®. How can we help you?
Our products
Looking to strengthen your analysis portfolio with standardized microbiota tests? Our product range includes standardized solutions for microbiota profiling in both research and clinical diagnostics.
Our services
GA-map® offers solutions to facilitate research in academia and pharma/industry. We provide services ranging from end-to-end microbiota analyses and bioinformatics to bacteria biomarker discovery and assay development.
Our products
GA-map® Dysbiosis Test
GA-map® Discovery
Sample Collection Kit
COVID-19 Fecal Test
We used GA-map® in our clinical research within IBS. We have great experience with GA-map® as a tool to select, monitor and follow-up patients.
Professor Magdy El-Salhy
Stord Hospital, Helse Bergen and the University of Bergen, Norway
There is still so much to learn about the microbiome, we are only just beginning to discover its importance, and the GA-map® Dysbiosis Test will help us do just that.
Emeritus Professor Peter Malfertheiner
Senior Professor at the Ludwig Maximillian University, University Clinic in Munich, Germany
Latest from GA-map®
GA-map® MHI GutHealth reagent kit is here!
Genetic Analysis launches a new Research Use Only assay. The GA-map® MHI GutHealth is a new tool for gut microbiome health assessment through a single, standardized score – the Microbiome Health Index (MHI). Validated in patients with recurrent Clostridioides difficile infection (rCDI), the test holds much broader potential for use in patient groups in need of microbiome restoration. The MHI biomarker is owned by Ferring Pharmaceuticals and licensed to Genetic Analysis on a non-exclusive basis. The biomarker has been adapted to the GA-map® platform to deliver a robust, ready-to-use solution for microbiome health assessment.
Industry partners
